World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
41298
World Ranking
6024
National Ranking
343

Overview

Albert Schömig is affiliated with the Technical University of Munich in Germany. Their research spans multiple fields, primarily focusing on medicine and engineering, with particular expertise in biomedical engineering, surgery, and cardiology and cardiovascular medicine.

The scientist's work encompasses key topics within cardiovascular health and technology. These include mechanical circulatory support devices, cardiac structural anomalies and repair, cardiac arrest and resuscitation, coronary interventions and diagnostics, cardiac valve diseases and treatments, cardiovascular function and risk factors, and artificial intelligence applications in healthcare and education.

Albert Schömig has published research in several recognized academic journals, including:

  • The Lancet
  • Journal of the American Heart Association
  • Journal of Clinical Medicine

Notable recent papers authored or co-authored by Schömig include:

  • "Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up" (2024, The Lancet)
  • "Ten-Year Clinical Outcomes of Biodegradable Versus Durable Polymer New-Generation Drug-Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus" (2021, Journal of the American Heart Association)
  • "Machine Learning Identifies New Predictors on Restenosis Risk after Coronary Artery Stenting in 10,004 Patients with Surveillance Angiography" (2023, Journal of Clinical Medicine)

Collaborative efforts are evident in Schömig's publication record, with frequent co-authors including Melchior Seyfarth, Adnan Kastrati, Jacob Eifer Møller, Josè P.S. Henriques, and Daniel Burkhoff.

Best Publications

  • Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

    Christoph Stettler;Christoph Stettler;Simon Wandel;Sabin Allemann;Adnan Kastrati

  • Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

    Alessandra Moretti;Milena Bellin;Andrea Welling;Christian Billy Jung

  • A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction

    Melchior Seyfarth;Dirk Sibbing;Iris Bauer;Georg Fröhlich

  • Estimated Radiation Dose Associated With Cardiac CT Angiography

    Jörg Hausleiter;Tanja Meyer;Franziska Hermann;Martin Hadamitzky

  • Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

    Adnan Kastrati;Julinda Mehilli;Josef Dirschinger;Franz Dotzer

  • Radiation dose estimates from cardiac multislice computed tomography in daily practice: impact of different scanning protocols on effective dose estimates.

    Jörg Hausleiter;Tanja Meyer;Martin Hadamitzky;Ester Huber

  • Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

    Adnan Kastrati;Julinda Mehilli;Nicolas von Beckerath;Alban Dibra

  • Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial

    Adnan Kastrati;Julinda Mehilli;Franz-Josef Neumann;Franz Dotzer

  • Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

    Franz-Josef Neumann;Adnan Kastrati;Gisela Pogatsa-Murray;Julinda Mehilli

  • Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients

    Alban Dibra;Adnan Kastrati;Julinda Mehilli;Jürgen Pache

  • Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel

    Dirk Sibbing;Tanja Morath;Julia Stegherr;Siegmund Braun

  • A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

    Adnan Kastrati;Julinda Mehilli;Helmut Schühlen;Josef Dirschinger

  • Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction

    Albert Schömig;Adnan Kastrati;Josef Dirschinger;Julinda Mehilli

  • Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.

    Gjin Ndrepepa;Peter B. Berger;Julinda Mehilli;Melchior Seyfarth

  • 5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

    Gjin Ndrepepa;Klaus Tiroch;Massimiliano Fusaro;Dritan Keta

  • Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement.

    Iris Müller;Melchior Seyfarth;Silja Rüdiger;Beate Wolf

  • Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial Infarction: A Randomized Controlled Trial

    Dietlind Zohlnhöfer;Ilka Ott;Julinda Mehilli;Kathrin Schömig

  • Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction

    Adnan Kastrati;Alban Dibra;Christian Spaulding;Gerrit J Laarman

  • Restenosis after coronary placement of various stent types

    Adnan Kastrati;Julinda Mehilli;Josef Dirschinger;Jürgen Pache

  • Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.

    Julinda Mehilli;Adnan Kastrati;Stefanie Schulz;Stefan Früngel

Frequent Co-Authors

Adnan Kastrati
Adnan Kastrati Technical University of Munich
Julinda Mehilli
Julinda Mehilli Ludwig-Maximilians-Universität München
Franz-Josef Neumann
Franz-Josef Neumann University of Freiburg
Robert A. Byrne
Robert A. Byrne Royal College of Surgeons in Ireland
Jörg Hausleiter
Jörg Hausleiter Ludwig-Maximilians-Universität München
Markus Schwaiger
Markus Schwaiger Technical University of Munich
Steffen Massberg
Steffen Massberg Ludwig-Maximilians-Universität München
Wolfgang Kübler
Wolfgang Kübler Heidelberg University
Peter B. Berger
Peter B. Berger Duke University
Stephan G. Nekolla
Stephan G. Nekolla Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but want to explore alternative or complementary career pathways, online health degrees provide flexible and accelerated options. For those looking to step into the healthcare management field quickly, accelerated healthcare programs can prepare you for leadership roles in less time than a traditional route.

Registered nurses who wish to advance their practice and scope can benefit from specialized rn to np programs, which offer a seamless transition from bedside nursing to becoming a nurse practitioner through flexible online bridge curriculums.

Those interested in nutrition and public health can consider enrolling in an online bachelor's degree in nutrition, paving the way for careers in dietetics, health education, or wellness coaching.

Aspiring healthcare executives should explore cahme-accredited online mha programs, which combine rigorous academics with the convenience of remote learning—ideal for building leadership capabilities in a fast-changing healthcare environment.

Best Scientists Citing Albert Schömig

Trending Scientists

Recently Published Articles